Peter C Ambe1, Stefan Jansen2, Susanne Macher-Heidrich3, Hubert Zirngibl2. 1. Department of Surgery II, Helios Universitätsklinikum Wuppertal, Witten - Herdecke University, Heusnerstr. 40, 42283, Wuppertal, Germany. Peter.ambe@helios-kliniken.de. 2. Department of Surgery II, Helios Universitätsklinikum Wuppertal, Witten - Herdecke University, Heusnerstr. 40, 42283, Wuppertal, Germany. 3. Institute of Quality Control in Health Care, Medical Association Nordrhein Westphalia, Tersteegenstr. 9, 40474, Düsseldorf, Germany.
Abstract
BACKGROUND: Acute cholecystitis is a common indication for surgery. Surgical outcomes depend among other factors on the extent of gallbladder inflammation. Data on the outcomes of patients undergoing cholecystectomy due to acute empyematous cholecystitis are rare. METHODS: Data from a prospectively maintained quality control database in Germany were analyzed. Cases with empyematous cholecystitis were compared to cases without gallbladder empyema with regard to baseline features, clinical parameters and surgical outcomes. RESULTS: A total of 12,069 patients with empyematous cholecystitis (EC) were compared to 33,296 patients without empyema. The male gender, advanced age, ASA score >2, elevated white blood count and fever were confirmed as risk factors for EC. The EC group differed significantly from the control group with regard to fever (28.0 vs. 9.5 %), elevated WBC (82.5 vs. 62.3 %) and positive findings from ultrasound sonography (87.4 vs. 76.9 %), p < 0001. Surgery lasted significantly longer in the EC group (86.1 ± 38.5 vs. 72.2 ± 33.6, p < 0.001). The rates of conversion (15.2 vs. 5.8 %), bile duct injury (0.8 vs. 0.4 %), re-intervention (5.5 vs. 2.6 %) and mortality (2.8 vs. 1.2 %) were significantly higher in the EC group, p < 0.001. Similarly, the length of stay (11.9 ± 10.5 vs. 8.8 ± 8.3, p < 0.001) was significantly longer in the EC group. CONCLUSION: Empyematous cholecystitis is a severe form of acute cholecystitis with high rates of morbidity and mortality. Even the experienced laparoscopic surgeon should expect dissection difficulties, therefore the threshold for conversion in order to prevent bile duct injury should be low.
BACKGROUND:Acute cholecystitis is a common indication for surgery. Surgical outcomes depend among other factors on the extent of gallbladder inflammation. Data on the outcomes of patients undergoing cholecystectomy due to acute empyematous cholecystitis are rare. METHODS: Data from a prospectively maintained quality control database in Germany were analyzed. Cases with empyematous cholecystitis were compared to cases without gallbladder empyema with regard to baseline features, clinical parameters and surgical outcomes. RESULTS: A total of 12,069 patients with empyematous cholecystitis (EC) were compared to 33,296 patients without empyema. The male gender, advanced age, ASA score >2, elevated white blood count and fever were confirmed as risk factors for EC. The EC group differed significantly from the control group with regard to fever (28.0 vs. 9.5 %), elevated WBC (82.5 vs. 62.3 %) and positive findings from ultrasound sonography (87.4 vs. 76.9 %), p < 0001. Surgery lasted significantly longer in the EC group (86.1 ± 38.5 vs. 72.2 ± 33.6, p < 0.001). The rates of conversion (15.2 vs. 5.8 %), bile duct injury (0.8 vs. 0.4 %), re-intervention (5.5 vs. 2.6 %) and mortality (2.8 vs. 1.2 %) were significantly higher in the EC group, p < 0.001. Similarly, the length of stay (11.9 ± 10.5 vs. 8.8 ± 8.3, p < 0.001) was significantly longer in the EC group. CONCLUSION:Empyematous cholecystitis is a severe form of acute cholecystitis with high rates of morbidity and mortality. Even the experienced laparoscopic surgeon should expect dissection difficulties, therefore the threshold for conversion in order to prevent bile duct injury should be low.
Entities:
Keywords:
Acute cholecystitis; Bile duct injury; Conversion to open cholecystectomy; Empyematous cholecystitis; Gallbladder empyema; Laparoscopic cholecystectomy
Authors: Carsten N Gutt; Jens Encke; Jörg Köninger; Julian-Camill Harnoss; Kilian Weigand; Karl Kipfmüller; Oliver Schunter; Thorsten Götze; Markus T Golling; Markus Menges; Ernst Klar; Katharina Feilhauer; Wolfram G Zoller; Karsten Ridwelski; Sven Ackmann; Alexandra Baron; Michael R Schön; Helmut K Seitz; Dietmar Daniel; Wolfgang Stremmel; Markus W Büchler Journal: Ann Surg Date: 2013-09 Impact factor: 12.969
Authors: Mehrdad Nikfarjam; Vachara Niumsawatt; Arun Sethu; Michael A Fink; Vijayaragavan Muralidharan; Graham Starkey; Robert M Jones; Christopher Christophi Journal: HPB (Oxford) Date: 2011-06-03 Impact factor: 3.647
Authors: Mehrdad Nikfarjam; Lilly Shen; Michael A Fink; Vijayaragavan Muralidharan; Graham Starkey; Robert M Jones; Christopher Christophi Journal: Surg Laparosc Endosc Percutan Tech Date: 2013-10 Impact factor: 1.719
Authors: Stefan Jansen; Johannes Doerner; Susanne Macher-Heidrich; Hubert Zirngibl; Peter C Ambe Journal: Surg Endosc Date: 2016-08-23 Impact factor: 4.584
Authors: Natallia Kharytaniuk; Gary A Bass; Bogdan D Dumbrava; Paul P Healy; Dylan Viani-Walsh; Tej N Tiwary; Tahir Abassi; Matthew P Murphy; Emma Griffin; Thomas N Walsh Journal: Surg Endosc Date: 2019-11-25 Impact factor: 4.584
Authors: Stefan Jansen; Maciej Stodolski; Hubert Zirngibl; Daniel Gödde; Peter C Ambe Journal: World J Emerg Surg Date: 2018-02-20 Impact factor: 5.469
Authors: Jennifer Blythe; Eva Herrmann; Dominik Faust; Stephan Falk; Tina Edwards-Lehr; Florian Stockhausen; Ernst Hanisch; Alexander Buia Journal: Pragmat Obs Res Date: 2018-10-25